Saturday, November 6, 2021
- 8:30AM-10:30AM
-
Abstract Number: 0096
The True Prevalence of SARS-CoV-2 Infection in an Italian Cohort of Patients with Inflammatory Arthritis: A Seroepidemiological Study
Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)- 8:30AM-10:30AM
-
Abstract Number: 0140
Therapeutic Management and Clinical Remission in a Specialized Dermatological-Rheumatological Center for Patients with Psoriasis and Psoriatic Arthritis
Health Services Research Poster I: Lupus, Inflammatory Arthritis, & More (0128–0148)- 8:30AM-10:30AM
-
Abstract Number: 0247
Three-year Effectiveness in Patients with JIA Initiating Abatacept: Results from the PRCSG/PRINTO JIA Real-World Registry
Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)- 8:30AM-10:30AM
-
Abstract Number: 0081
Thrombin Generation Assay and Lupus Anticoagulant Identify Different Populations of Patients with Antiphospholipid Antibodies
Antiphospholipid Syndrome Poster (0069–0083)- 8:30AM-10:30AM
-
Abstract Number: 0055
Time Course of Intestinal Permeability and Intestinal Inflammation in Rat Adjuvant-induced Arthritis
Spondyloarthritis Including PsA – Basic Science Poster (0046–0068)- 8:30AM-10:30AM
-
Abstract Number: 0087
TNF Inhibitors and the Risk of Adverse COVID-19 Outcomes in Patients with Immune-Mediated Inflammatory Disease: Pooled Data from Three Global Registries
Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)- 8:30AM-10:30AM
-
Abstract Number: 0193
Tocilizumab for the Treatment of Familial Mediterranean Fever – a Randomized, Double Blind, Placebo-controlled Phase II Study
Miscellaneous Rheumatic & Inflammatory Diseases Poster I (0183–0209)- 8:30AM-10:30AM
-
Abstract Number: 0139
Treatment of Ankylosing Spondylitis by Primary Care Physicians and Rheumatologists in an Academic Health System: A Retrospective Study
Health Services Research Poster I: Lupus, Inflammatory Arthritis, & More (0128–0148)- 8:30AM-10:30AM
-
Abstract Number: 0207
Treatment of Ocular Sarcoidosis: Study of 65 Patients of a Series of 384 Patients from a Single University Hospital
Miscellaneous Rheumatic & Inflammatory Diseases Poster I (0183–0209)- 8:30AM-10:30AM
-
Abstract Number: 0138
Treatment with Adalimumab in Patients with Chronic Inflammatory Rheumatic Diseases: A Study of Treatment Trajectories on a Patient Level in Clinical Practice
Health Services Research Poster I: Lupus, Inflammatory Arthritis, & More (0128–0148)- 8:30AM-10:30AM
-
Abstract Number: 0339
Trends in Disparity by Age, Sex and Race for Systemic Lupus Erythematosus Patients
SLE – Diagnosis, Manifestations, & Outcomes Poster I: Diagnosis (0323–0356)- 8:30AM-10:30AM
-
Abstract Number: 0221
Trunk Movement Compensation Is Associated with Physical Performance Measures and Fatigue Deficits in Hip Osteoarthritis
Osteoarthritis – Clinical Poster I (0210–0224)- 8:30AM-10:30AM
-
Abstract Number: 0311
Ultra High‐frequency Ultrasound (UHFUS) of Labial Glands in Primary Sjögren’s Syndrome: Serological and Histological Correlations
Sjögren's Syndrome – Basic & Clinical Science Poster (0296–0322)- 8:30AM-10:30AM
-
Abstract Number: 0215
Ultrasonographic Assessment of Knee Osteoarthritis and Its Agreement with Radiography